...
首页> 外文期刊>Oncoimmunology. >The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells:Implications for pancreatic cancer-driven immunosuppression.
【24h】

The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells:Implications for pancreatic cancer-driven immunosuppression.

机译:S100A8 / A9复合物通过未成熟的髓样细胞减少CTLA4的表达:对胰腺癌驱动的免疫抑制的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

An expansion of different myeloid derived suppressive cell (MDSC) subsets can be detected in the blood and secondary lymphoid organs of early and advancedpancreatic ductal adenocarcinoma (PDAC) patients. Double negative(CD14(-)HLA-DR(-)) MDSCs are frequently induced by PDACs. In addition, byreleasing S100A8 and S100A9, advanced PDAC lesions cause an expansion of highlyimmunosuppressive CD33(+)CD14(+)HLA-DR(-) monocytic MDSCs expressing low levelsof cytotoxic T lymphocyte antigen 4 (CTLA4) on the cell surface.
机译:可以在早期和晚期胰腺导管腺癌(PDAC)患者的血液和继发性淋巴器官中检测到不同的髓样衍生抑制细胞(MDSC)亚型的扩增。双负(CD14(-)HLA-DR(-))MDSC通常由PDAC诱导。此外,通过释放S100A8和S100A9,晚期PDAC损伤会引起高度免疫抑制性CD33(+)CD14(+)HLA-DR(-)单核MDSC的扩增,在细胞表面表达低水平的细胞毒性T淋巴细胞抗原4(CTLA4)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号